In last trading session, Outlook Therapeutics Inc (NASDAQ:OTLK) saw 62.14 million shares changing hands with its beta currently measuring 0.61. Company’s recent per share price level of $1.70 trading at -$3.19 or -65.24% at ring of the bell on the day assigns it a market valuation of $13.98M. That closing price of OTLK’s stock is at a discount of -655.88% from its 52-week high price of $12.85 and is indicating a discount of -171.18% from its 52-week low price of $4.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.48 million shares which gives us an average trading volume of 277.48K if we extend that period to 3-months.
For Outlook Therapeutics Inc (OTLK), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.9 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Outlook Therapeutics Inc (NASDAQ:OTLK) trade information
Upright in the red during last session for losing -65.24%, in the last five days OTLK remained trading in the red while hitting it’s week-highest on Thursday, 11/21/24 when the stock touched $1.70 price level, adding 67.86% to its value on the day. Outlook Therapeutics Inc’s shares saw a change of -78.43% in year-to-date performance and have moved -67.80% in past 5-day. Outlook Therapeutics Inc (NASDAQ:OTLK) showed a performance of -70.38% in past 30-days. Number of shares sold short was 3.4 million shares which calculate 11.43 days to cover the short interests.
Outlook Therapeutics Inc (OTLK) estimates and forecasts
Statistics highlight that Outlook Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -76.45% of value to its shares in past 6 months, showing an annual growth rate of 20.00% while that of industry is 17.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 52.49% during past 5 years.
Outlook Therapeutics Inc (NASDAQ:OTLK)’s Major holders
Insiders are in possession of 35.58% of company’s total shares while institution are holding 35.65 percent of that, with stock having share float percentage of 55.34%. Investors also watch the number of corporate investors in a company very closely, which is 35.65% institutions for Outlook Therapeutics Inc that are currently holding shares of the company. ROSALIND ADVISORS, INC. is the top institutional holder at OTLK for having 0.45 million shares of worth $3.32 million. And as of 2024-06-30, it was holding 3.1534 of the company’s outstanding shares.
On the other hand, Vanguard Extended Market Index Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 30, 2024 , the former fund manager was holding 283.49 shares of worth $0.48 million or 1.20% of the total outstanding shares. The later fund manager was in possession of 204.51 shares on Jun 30, 2024 , making its stake of worth around $0.35 million in the company or a holder of 0.86% of company’s stock.
